NCT03397914View on ClinicalTrials.gov

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions
Gram-Negative Bacterial InfectionsPediatric CancerColistinColistin Adverse ReactionMIC
Interventions
DRUG

Colistimethate Sodium

Intravenous injection of colistimethate Sodium 2.5 mg/kg or 5 mg/kg for Multidrug-resistance gram negative infections

Trial Locations (1)

Unknown

Iman Sidhom, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT03397914 - Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | Biotech Hunter | Biotech Hunter